Abaloparatide Pregnancy and Breastfeeding Warnings
Brand names: Tymlos
Medically reviewed by Drugs.com. Last updated on Jan 10, 2025.
Abaloparatide Pregnancy Warnings
This drug is not indicated for use in females of reproductive potential
US FDA pregnancy category: Not assigned
Risk summary: No data available on the use of this drug in pregnant women to inform a drug-related risk.
Animal reproduction studies have not been conducted. There are no controlled data in human pregnancy.
Abaloparatide Breastfeeding Warnings
This drug is not indicated for use in females of reproductive potential
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: There is no information on the presence of this drug in human milk, the effects on the breastfed infant, or the effects on milk production.
See also
References for pregnancy information
- (2017) "Product Information. Tymlos (abaloparatide)." Radius Health
References for breastfeeding information
- (2017) "Product Information. Tymlos (abaloparatide)." Radius Health
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.